Inspire Medical Systems Lowers FY2026 GAAP EPS Guidance from $1.23-$1.81 to $0.07-$0.62 vs $1.63 Est

Benzinga Newsdesk www.benzinga.com Negative 96.4%

Neg 96.4% Neu 0% Pos 0%

Inspire Medical Systems (NYSE:INSP) lowers FY2026 GAAP EPS guidance from $1.23-$1.81 to $0.07-$0.62 vs $1.63 analyst estimate..